Large gap with delayed quotes
|
Last quote
02/28/2026
-
02:00:00
|
Bid
02/27/2026 -
21:59:59
|
Bid Volume |
Ask
02/27/2026 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
275.64
-0.72
(
-0.26% )
|
275.09
|
1,000 |
275.71
|
100 |
Analysis date: 24.02.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 02.01.2026.
Interest
Weak
Weak
Two stars since 24.02.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 24.02.2026 at a price of 266.90.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 16.09.2025.
4wk Rel Perf
-4.83%
-4.83%
The four-week dividend-adjusted underperformance versus SP500 is 4.83%.
Sensibility
High
High
High, no change over 1 year.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.00%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 4.57%.
Mkt Cap in $bn
7.80
7.80
With a market capitalization between $2 & $8bn, KRYSTAL BIOTECH is considered a mid-cap stock.
G/PE Ratio
0.83
0.83
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
24.72
24.72
The estimated PE is for the year 2028.
LT Growth
20.56%
20.56%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
9
9
Over the last seven weeks, an average of 9 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
45
45
For 1% of index variation, the stock varies on average by 0.45%.
Correlation
0.19
0.19
Stock movements are totally independent of index variations.
Value at Risk
90.28
90.28
The value at risk is estimated at USD 90.28. The risk is therefore 33.83%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
22.11.2024
22.11.2024